Net Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2014

Earnings Per Share [Abstract]

Reconciliation Of The Numerator And Denominator Of Basic And Diluted Net (Loss) Income Per Share

The following is a reconciliation of the numerator and denominator of basic and diluted net (loss) income per share for the three months ended March 31, 2014 and 2013 (in thousands, except per share data):

	Three Months Ended March 31,
	2014			2013
Numerator:
(Loss) income from continuing operations	$	(438,697	)	$	21,653
Less: Net income from continuing operations attributable to noncontrolling interests	100			—
(Loss) income from continuing operations attributable to Endo International plc ordinary shareholders	(438,797		)	21,653
Income (loss) from discontinued operations attributable to Endo International plc ordinary shareholders, net of tax	1,885			(6,304		)
Net (loss) income attributable to Endo International plc ordinary shareholders	$	(436,912	)	$	15,349
Denominator:
For basic per share data—weighted average shares	128,135			111,216
Dilutive effect of ordinary share equivalents	—			1,952
Dilutive effect of 1.75% Convertible Senior Subordinated Notes and warrants	—			21
For diluted per share data—weighted average shares	128,135			113,189

Reconciliation Of Maximum Potential Dilution Of Shares Currently Excluded From The Calculation Of Diluted Net Income Per Share

The following reconciliation shows the maximum potential dilution of shares currently excluded from the diluted net (loss) income per share calculations for the three months ended March 31, 2014 and 2013 (in thousands):

	Three Months Ended March 31,
	2014	2013
Weighted average shares excluded:
1.75% Convertible senior subordinated notes due 2015 and warrants(1)	25,993	25,972
Employee share-based awards	178	4,422
Total excluded shares	26,171	30,394

__________

(1) Amounts represent the incremental potential total dilution that could occur if our Convertible Notes and warrants were converted to ordinary shares.